Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 146 JPY -1.35% Market Closed
Market Cap: 9.4B JPY
Have any thoughts about
Modalis Therapeutics Corp?
Write Note

Modalis Therapeutics Corp
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Modalis Therapeutics Corp
Net Income Peer Comparison

Comparables:
2160
4587
4974
2929
C
4894

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Modalis Therapeutics Corp
TSE:4883
Net Income
-ÂĄ2.4B
CAGR 3-Years
-76%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Net Income
ÂĄ8.3B
CAGR 3-Years
56%
CAGR 5-Years
56%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Net Income
ÂĄ30.2B
CAGR 3-Years
80%
CAGR 5-Years
51%
CAGR 10-Years
63%
Takara Bio Inc
TSE:4974
Net Income
ÂĄ841m
CAGR 3-Years
-66%
CAGR 5-Years
-31%
CAGR 10-Years
-11%
Pharma Foods International Co Ltd
TSE:2929
Net Income
ÂĄ5B
CAGR 3-Years
-4%
CAGR 5-Years
50%
CAGR 10-Years
83%
C
Cuorips Inc
TSE:4894
Net Income
-ÂĄ630m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Modalis Therapeutics Corp's Net Income?
Net Income
-2.4B JPY

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Net Income amounts to -2.4B JPY.

What is Modalis Therapeutics Corp's Net Income growth rate?
Net Income CAGR 5Y
-62%

Over the last year, the Net Income growth was 12%. The average annual Net Income growth rates for Modalis Therapeutics Corp have been -76% over the past three years , -62% over the past five years .

Back to Top